BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9583589)

  • 1. Effects of isoproterenol on blood-brain barrier permeability in rats.
    Chi OZ; Wang G; Chang Q; Weiss HR
    Neurol Res; 1998 Apr; 20(3):259-64. PubMed ID: 9583589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of topical N-methyl-D-aspartate on blood-brain barrier permeability in the cerebral cortex of normotensive and hypertensive rats.
    Chi OZ; Chang Q; Weiss HR
    Neurol Res; 1997 Oct; 19(5):539-44. PubMed ID: 9329033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
    Chi OZ; Chun TW; Liu X; Weiss HR
    Anesth Analg; 1998 Jun; 86(6):1230-5. PubMed ID: 9620510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex.
    Chi OZ; Hunter C; Liu X; Weiss HR
    Neurol Res; 2005 Dec; 27(8):864-8. PubMed ID: 16354548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endothelin-1 on blood-brain barrier permeability during focal cerebral ischemia in rats.
    Chi OZ; Liu X; Weiss HR
    Exp Brain Res; 2001 Nov; 141(1):1-5. PubMed ID: 11685406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
    Chi OZ; Lu X; Wei HM; Williams JA; Weiss HR
    Anesth Analg; 1996 Aug; 83(2):336-41. PubMed ID: 8694315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fentanyl on alpha-aminoisobutyric acid transfer across the blood-brain barrier.
    Chi OZ; Wei HM; Anwar M; Sinha AK; Klein SL; Weiss HR
    Anesth Analg; 1992 Jul; 75(1):31-6. PubMed ID: 1616157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 17beta-estradiol on blood-brain barrier disruption in focal ischemia during GABA(A) receptor inhibition.
    Chi OZ; Hunter C; Liu X; Weiss HR
    Horm Metab Res; 2005 Apr; 37(4):209-13. PubMed ID: 15952079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metabotropic glutamate receptor stimulation on blood-brain barrier permeability during focal cerebral ischemia.
    Liu X; Chi OZ; Weiss HR
    Neurochem Res; 2004 Oct; 29(10):1857-62. PubMed ID: 15532541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclic GMP on microvascular permeability of the cerebral cortex.
    Chi OZ; Liu X; Weiss HR
    Microvasc Res; 1999 Jul; 58(1):35-40. PubMed ID: 10388601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts.
    Nasa Y; Yabe K; Takeo S
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):436-43. PubMed ID: 9156351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of erythropoietin on blood-brain barrier disruption in focal cerebral ischemia.
    Chi OZ; Hunter C; Liu X; Weiss HR
    Pharmacology; 2008; 82(1):38-42. PubMed ID: 18434762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of GABA(A) receptor blockade on regional cerebral blood flow and blood-brain barrier disruption in focal cerebral ischemia.
    Chi OZ; Hunter C; Liu X; Chi Y; Weiss HR
    J Neurol Sci; 2011 Feb; 301(1-2):66-70. PubMed ID: 21094956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of deferoxamine on blood-brain barrier disruption and VEGF in focal cerebral ischemia.
    Chi OZ; Hunter C; Liu X; Weiss HR
    Neurol Res; 2008 Apr; 30(3):288-93. PubMed ID: 17767813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of VEGF on the blood-brain barrier disruption caused by hyperosmolarity.
    Chi OZ; Hunter C; Liu X; Tan T; Weiss HR
    Pharmacology; 2008; 82(3):187-92. PubMed ID: 18708733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat.
    Alvarez-Guerra M; Alda O; Garay RP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 17beta-estradiol on blood-brain barrier disruption during focal ischemia in rats.
    Chi OZ; Liu X; Weiss HR
    Horm Metab Res; 2002 Sep; 34(9):530-4. PubMed ID: 12384831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors alpha1, beta and beta2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractions.
    Danuser H; Weiss R; Abel D; Walter B; Scholtysik G; Mettler D; Studer UE
    J Urol; 2001 Aug; 166(2):714-20. PubMed ID: 11458123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.